UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 596

Sortiert nach

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

British journal of haematology, 2020-06, Vol.189 (5), p.846-847

2020

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in COVID-19: A systematic review and meta-analysis

Vascular medicine (London, England), 2021-08, Vol.26 (4), p.415-425

2021

Link zum Volltext

Verfügbarkeit prüfen

High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling

Clinical cancer research, 2019-09, Vol.25 (18), p.5503-5512

2019

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors

Journal of thoracic oncology, 2018-08, Vol.13 (8), p.1076-1082

2018

Link zum Volltext

Verfügbarkeit prüfen

Objective measurement and clinical significance of TILs in non-small cell lung cancer

JNCI : Journal of the National Cancer Institute, 2015-03, Vol.107 (3), p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer

Clinical cancer research, 2018-04, Vol.24 (7), p.1562-1573

2018

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer in never smokers: Disease characteristics and risk factors

Critical reviews in oncology/hematology, 2013-12, Vol.88 (3), p.494-503

2013

Link zum Volltext

Verfügbarkeit prüfen

Programmed death ligand-1 expression in non-small cell lung cancer

Laboratory investigation, 2014-01, Vol.94 (1), p.107-116

2014

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.665-673

2014

Link zum Volltext

Verfügbarkeit prüfen

The VEGF pathway in lung cancer

Cancer chemotherapy and pharmacology, 2013-12, Vol.72 (6), p.1169-1181

2013

Link zum Volltext

Verfügbarkeit prüfen

Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review

Critical reviews in oncology/hematology, 2013-07, Vol.87 (1), p.1-11

2013

Link zum Volltext

Verfügbarkeit prüfen

MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis

PloS one, 2014-09, Vol.9 (9), p.e107677-e107677

2014

Link zum Volltext

Verfügbarkeit prüfen

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

Clinical cancer research, 2019-03, Vol.25 (5), p.1526-1534

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.127-133

2020

Link zum Volltext

Verfügbarkeit prüfen

Programmed death ligand-1 expression in non-small cell lung cancer

Laboratory investigation, 2014-01, Vol.94 (1), p.107-116

2014

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity in reporting venous thromboembolic phenotypes in COVID‐19: methodological issues and clinical implications

British journal of haematology, 2020-08, Vol.190 (4), p.529-532

2020

Link zum Volltext

Verfügbarkeit prüfen

Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

Cancers, 2023-02, Vol.15 (4), p.1286

2023

Link zum Volltext

Verfügbarkeit prüfen

An open label trial of anakinra to prevent respiratory failure in COVID-19

eLife, 2021-03, Vol.10

2021

Link zum Volltext

Verfügbarkeit prüfen

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Clinical cancer research, 2017-09, Vol.23 (17), p.5202-5209

2017

Link zum Volltext

Verfügbarkeit prüfen

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1884-1896

2018

Link zum Volltext

Verfügbarkeit prüfen

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases

Cancers, 2023-05, Vol.15 (9), p.2637

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment

Frontiers in oncology, 2020-07, Vol.10, p.1221-1221

2020

Link zum Volltext

Verfügbarkeit prüfen

The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13), p.3634-3644

2018

Link zum Volltext

Verfügbarkeit prüfen

The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis

Anticancer research, 2014-09, Vol.34 (9), p.4665-4672

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 596

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(428)
Mit Volltextzugriff
(506)

Publikationsform

Sprache

Englisch
(592)
Japanisch
(39)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

Venous thromboembolism in COVID-19: A systematic review and meta-analysis

High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors

Objective measurement and clinical significance of TILs in non-small cell lung cancer

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer

Lung cancer in never smokers: Disease characteristics and risk factors

Programmed death ligand-1 expression in non-small cell lung cancer

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The VEGF pathway in lung cancer

Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review

MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making

Programmed death ligand-1 expression in non-small cell lung cancer

Heterogeneity in reporting venous thromboembolic phenotypes in COVID‐19: methodological issues and clinical implications

Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

An open label trial of anakinra to prevent respiratory failure in COVID-19

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases

The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment

The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis

The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis

Suchergebnisse filtern